9 Paul Tudor Jones II Xeris Biopharma Holdings Trades
Paul Tudor Jones II's position in Xeris Biopharma Holdings is currently worth $1.53 Million. That's 0.02% of their equity portfolio (774th largest holding). The first Xeris Biopharma Holdings trade was made in Q4 2021. Since then Paul Tudor Jones II bought shares two more times and sold shares on six occasions. The stake costed the investor $662 Thousand, netting the investor a gain of 131% so far.
Avg closing price
Price range
Sold 39.8% shares (-202 Thousand shares)
Q4 2024
Avg closing price
$3.23
Price range
$2.78
-
$3.73
Sold 11.5% shares (-65.8 Thousand shares)
Q3 2024
Avg closing price
$2.56
Price range
$2.06
-
$2.96
Increased shares by 3.6% (+19.8 Thousand shares)
Q1 2024
Avg closing price
$2.59
Price range
$2.04
-
$3.22
Sold 13.7% shares (-88.1 Thousand shares)
Q4 2023
Avg closing price
$1.85
Price range
$1.47
-
$2.36
Sold 25.3% shares (-217 Thousand shares)
Q3 2023
Avg closing price
$2.29
Price range
$1.80
-
$2.69
Sold 10.6% shares (-102 Thousand shares)
Q2 2023
Avg closing price
$2.55
Price range
$1.82
-
$2.98
Sold 0.1% shares (-1.08 Thousand shares)
Q2 2022
Avg closing price
$2.11
Price range
$1.48
-
$2.64
Increased shares by 0.1% (+1.08 Thousand shares)
Q1 2022
Avg closing price
$2.44
Price range
$2.00
-
$2.87
New holding (+960 Thousand shares)
Q4 2021
Avg closing price
$2.16
Price range
$1.80
-
$2.93
